Ramaswamy Govindan, MD

Medical Oncologist

Ramaswamy Govindan

Appointment Options

Whether you’re seeking a new patient appointment or exploring treatment options and looking for a second opinion, our Siteman care coordinators are ready to assist you.

My Locations

Gary C. Werths Building at Siteman Cancer Center

Gary C. Werths Building at Siteman Cancer Center

On WashU Medicine Campus
4500 Forest Park Avenue, Saint Louis, MO 63108

Expertise & Training

Video thumbnail for Ramaswamy Govindan, MD

Watch video on YouTube

Ramaswamy Govindan, MD

2 mins

Washington University medical oncologist Ramaswamy Govindan, MD, discusses what esophageal, thoracic and lung cancer patients can expect from their extended care team at Siteman Cancer Center. Learn more about Dr. Govindan: https://siteman.wustl.edu/doctor/govindan-ramaswamy-md/

Learn more about the Siteman Approach to Esophageal Cancer: https://siteman.wustl.edu/treatment/cancer-types/esophageal/our-approach/

Learn more about the Siteman Approach to Lung Cancer: https://siteman.wustl.edu/treatment/cancer-types/lung-cancer/our-approach/

Lung cancer screening is improving patient outcomes at Siteman. Learn more: https://siteman.wustl.edu/how-siteman-is-revolutionizing-lung-cancer-screening-and-improving-patient-outcomes/

Clinical Expertise

  • As the Anheuser Busch Endowed Chair in Medical Oncology and a member of our esophageal and lung cancer specialist teams, Dr. Govindan cares for patients diagnosed with these cancers through treatment and recovery.

Primary Academic Title

Anheuser Busch Endowed Chair in Medical Oncology, Professor of Medicine, Division of Oncology and Director, Section of Medical Oncology, WashU Medicine

Board Certification

  • 1993: American Board of Internal Medicine, Internal Medicine
  • 1996: American Board of Internal Medicine, Hematology
  • 1997: American Board of Internal Medicine, Medical Oncology

Training

  • 1987 - 1991: Resident, Internal Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research, Pondicherry, India
  • 1991 - 1993: Intern and Resident, Internal Medicine, Michael Reese Hospital and Medical Center, Chicago, IL
  • 1993 - 1996: Fellow, Hematology and Oncology, WashU Medicine, St. Louis, MO

Education

  • 1986: MD, University of Madras, Madras, India

Research & Selected Publications

Research Interest

The management of lung cancer, mesothelioma and esophageal cancer as well as developing clinical trials for patients with non-small cell lung cancer.

Research Publications

Germline alterations in patients with lung cancer
Authors:

Govindan R, Navo K, Huang M, one or more additional authors omitted Cao Y

Journal & Year:

Ann Oncol | 2026

Accelerating discovery of cancer causes for prevention in the era of rising early-onset cancers
Authors:

Shi M, Patti GJ, Gunter MJ, Govindan R, one or more additional authors omitted Cao Y

Journal & Year:

Cell | 2026

Emerging options and future strategies in immunotherapy for advanced lung squamous-cell carcinoma
Authors:

Wang Y, Rosell R, Hirsch FR, one or more additional authors omitted Govindan R, one or more additional authors omitted Zhang JJ

Journal & Year:

Ann Oncol | 2026

Basal cell of origin resolves neuroendocrine-tuft lineage plasticity in cancer
Authors:

Ireland AS, Xie DA, Hawgood SB, one or more additional authors omitted Govindan R, one or more additional authors omitted Oliver TG

Journal & Year:

Nature | 2025

Smoking Cessation and Mortality Risk in Cancer Survivorship: Real-World Data From a National Cancer Institute-Designated Cancer Center
Authors:

Tohmasi S, Baker TB, Heiden BT, one or more additional authors omitted Govindan R, one or more additional authors omitted Chen LS

Journal & Year:

J Natl Compr Canc Netw | 2025

Integrative analysis of lung adenocarcinoma across diverse ethnicities and exposures
Authors:

Satpathy S, Clark NM, Chen YJ, one or more additional authors omitted Govindan R, one or more additional authors omitted Gillette MA

Journal & Year:

Cancer Cell | 2025

Immunotherapy for advanced-stage squamous cell lung cancer: the state of the art and outstanding questions
Authors:

Wang Y, Safi M, Hirsch FR, one or more additional authors omitted Govindan R, one or more additional authors omitted Zhang JJ

Journal & Year:

Nat Rev Clin Oncol | 2025

Safety and Tolerability of Letetresgene Autoleucel (GSK3377794): Pilot Studies in Patients with Advanced Non-Small Cell Lung Cancer
Authors:

Altan M, Lopes G, Hiltermann TJN, Govindan R, one or more additional authors omitted Schoenfeld AJ

Journal & Year:

Clin Cancer Res | 2025